Abstract
Coronaviruses are a class of large, enveloped, positive-sensed, single-stranded RNA viruses that cause infections in the respiratory tracts of mammals such as humans, bats, and other animals. Coronavirus disease 2019 (COVID-19), also known as 2019 new coronavirus (2019-nCoV), is an agile respiratory disease caused by a novel coronavirus that was first discovered in Wuhan, China. It has now expanded to 216 nations and killed over 0.5 million people worldwide, prompting the World Health Organization (WHO) to proclaim it a pandemic. Current review focuses on the role of herbs and herbs-derived secondary metabolites in inhibiting the SARS-CoV-2 virus as well as in the management of post-COVID-19 complications. This strategy will promote and protect the use of medicinal plant resources to support the healthcare system. Plant-derived phytochemicals have already been shown to prevent viral infection and to alleviate post-COVID complications such as parkinsonism, kidney and heart failure, liver and lung damage, and mental problems. We investigated mechanistic approaches of herbal medicines and their phytochemicals as antiviral and post-COVID complications by modulating immunological and inflammatory states in this review.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Asian Journal of Research in Pharmaceutical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
